Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 246

1.

Efficient regulation of VEGF expression by promoter-targeted lentiviral shRNAs based on epigenetic mechanism: a novel example of epigenetherapy.

Turunen MP, Lehtola T, Heinonen SE, Assefa GS, Korpisalo P, Girnary R, Glass CK, Väisänen S, Ylä-Herttuala S.

Circ Res. 2009 Sep 11;105(6):604-9. doi: 10.1161/CIRCRESAHA.109.200774. Epub 2009 Aug 20.

2.

Engineered zinc finger-activating vascular endothelial growth factor transcription factor plasmid DNA induces therapeutic angiogenesis in rabbits with hindlimb ischemia.

Dai Q, Huang J, Klitzman B, Dong C, Goldschmidt-Clermont PJ, March KL, Rokovich J, Johnstone B, Rebar EJ, Spratt SK, Case CC, Kontos CD, Annex BH.

Circulation. 2004 Oct 19;110(16):2467-75. Epub 2004 Oct 11.

5.

Inhibition of choroidal neovascularization by adenovirus-mediated delivery of short hairpin RNAs targeting VEGF as a potential therapy for AMD.

Cashman SM, Bowman L, Christofferson J, Kumar-Singh R.

Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3496-504.

PMID:
16877421
6.

[The effect of vascular endothelia growth factor encapsulated in nanoparticles on chronic limb ischemia].

Xu YY, Li YJ, Guan H, Liu CW, Zheng YH, Liu B, Yang J, Song CX.

Zhonghua Wai Ke Za Zhi. 2004 Jan 7;42(1):58-61. Chinese.

PMID:
14989853
7.
8.

Therapeutic arteriogenesis by ultrasound-mediated VEGF165 plasmid gene delivery to chronically ischemic skeletal muscle.

Leong-Poi H, Kuliszewski MA, Lekas M, Sibbald M, Teichert-Kuliszewska K, Klibanov AL, Stewart DJ, Lindner JR.

Circ Res. 2007 Aug 3;101(3):295-303. Epub 2007 Jun 21.

9.

Application of combination of short hairpin RNA segments for silencing VEGF, TERT and Bcl-xl expression in laryngeal squamous carcinoma.

Wang Y, Tao ZZ, Chen SM, Xiao BK, Zhou XH, Liu JP.

Cancer Biol Ther. 2008 Jun;7(6):896-901. Epub 2008 Mar 15.

PMID:
18367874
10.

Stable RNA interference: comparison of U6 and H1 promoters in endothelial cells and in mouse brain.

Mäkinen PI, Koponen JK, Kärkkäinen AM, Malm TM, Pulkkinen KH, Koistinaho J, Turunen MP, Ylä-Herttuala S.

J Gene Med. 2006 Apr;8(4):433-41.

PMID:
16389634
11.

Epigenetic upregulation of endogenous VEGF-A reduces myocardial infarct size in mice.

Turunen MP, Husso T, Musthafa H, Laidinen S, Dragneva G, Laham-Karam N, Honkanen S, Paakinaho A, Laakkonen JP, Gao E, Vihinen-Ranta M, Liimatainen T, Ylä-Herttuala S.

PLoS One. 2014 Feb 26;9(2):e89979. doi: 10.1371/journal.pone.0089979. eCollection 2014 Feb 26.

12.
13.

Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.

Guo B, Zhang Y, Luo G, Li L, Zhang J.

Anat Rec (Hoboken). 2009 May;292(5):633-9. doi: 10.1002/ar.20893.

14.

A quick and efficient approach for gene silencing by using triple putative microRNA-based short hairpin RNAs.

Shan ZX, Lin QX, Yang M, Deng CY, Kuang SJ, Zhou ZL, Xiao DZ, Liu XY, Lin SG, Yu XY.

Mol Cell Biochem. 2009 Mar;323(1-2):81-9. doi: 10.1007/s11010-008-9966-3. Epub 2008 Nov 27.

PMID:
19037714
15.

Lentivirus-mediated sFlt-1 gene fragment transfer suppresses retinal neovascularization.

Min Z, Qiang W, Benwen S, Bin L, Xinhua D.

Curr Eye Res. 2009 May;34(5):401-10. doi: 10.1080/02713680902862971.

PMID:
19401884
16.

Estrogen regulation of vascular endothelial growth factor in breast cancer in vitro and in vivo: the role of estrogen receptor alpha and c-Myc.

Dadiani M, Seger D, Kreizman T, Badikhi D, Margalit R, Eilam R, Degani H.

Endocr Relat Cancer. 2009 Sep;16(3):819-34. doi: 10.1677/ERC-08-0249. Epub 2009 Apr 27.

17.

Inhibition of vascular endothelial growth factor expression in keloid fibroblasts by vector-mediated vascular endothelial growth factor shRNA: a therapeutic potential strategy for keloid.

Zhang GY, Yi CG, Li X, Zheng Y, Niu ZG, Xia W, Meng Z, Meng CY, Guo SZ.

Arch Dermatol Res. 2008 Apr;300(4):177-84. doi: 10.1007/s00403-007-0825-y. Epub 2008 Feb 1.

PMID:
18239926
18.

HIV-1-mediated delivery of a short hairpin RNA targeting vascular endothelial growth factor in human retinal pigment epithelium cells.

Lombardi G, Calistri A, Curtarello M, Giudice GL, Piermarocchi S, Prosdocimo G, Palù G, Parolin C.

Br J Ophthalmol. 2009 Feb;93(2):244-8. doi: 10.1136/bjo.2008.138388.

PMID:
19174401
19.

Transcriptional regulation by promoter targeted RNAs.

Suzuki K, Kelleher AD.

Curr Top Med Chem. 2009;9(12):1079-87. Review.

PMID:
19860708
20.

Inhibition of prolyl hydroxylase domain proteins promotes therapeutic revascularization.

Loinard C, Ginouvès A, Vilar J, Cochain C, Zouggari Y, Recalde A, Duriez M, Lévy BI, Pouysségur J, Berra E, Silvestre JS.

Circulation. 2009 Jul 7;120(1):50-9. doi: 10.1161/CIRCULATIONAHA.108.813303. Epub 2009 Jun 22.

Supplemental Content

Support Center